Semaglutide/Cyanocobalamin also slows the stomach emptying, leading to a feeling of fullness and reduced hunger
1 Sustained weight loss of 5-10% has been shown to significantly reduce the risk of developing obesity-related comorbidities, with the risk of developing diabetes reduced by up to 60% in overweight and obese adults who sustained weight loss for at least two years
Key takeaways Semaglutide was first approved by the FDA to treat type 2 diabetes under the brand name Ozempic in 2017
Injectable semaglutide supplies in Singapore are also inconsistent, with frequent supply shortages
Age: People in perimenopause may experience changes in their periods, while menopause is when menstruation has stopped for 12 consecutive months
Transitioning from Ozempic to Mounjaro can be a beneficial step for many patients with type 2 diabetes, offering the potential for improved blood sugar control and greater weight loss (despite the fact that both Mounjaro and Ozempic are effective diabetes management medications with an extensive list of potential benefits)